SCHEMBL27345370

SCHEMBL27345370

Cc1cccc(Nc2cc(N3CCCCC3CO)ncn2)c1

nearest known ligand 0.50

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
▸ EGFR P00533 2/20 0.50
▸ CDK1 P06493 3/20 0.43
▸ ADORA2A P29274 4/20 0.43
▸ ADORA1 P30542 4/20 0.43
▸ ADORA3 P0DMS8 3/20 0.43
▸ PIK3CA P42336 1/20 0.42
▸ PRKDC P78527 1/20 0.42
▸ TNNI3K Q59H18 1/20 0.41
▸ PRKCA P17252 1/20 0.40
▸ BCL6 P41182 1/20 0.40
▸ GBA1 P04062 1/20 0.39
▸ ITGB2 P05107 1/20 0.39
▸ ICAM1 P05362 1/20 0.39
▸ ITGAL P20701 1/20 0.39
▸ HTT P42858 1/20 0.39
▸ CNR2 P34972 1/20 0.39
▸ KHK P50053 1/20 0.39
▸ SCN9A Q15858 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27423218 0.84 EGFR (0.52) EGFRCDK1ADORA2AADORA1ADORA3
SCHEMBL27323457 0.80 EGFR (0.53) EGFRPIK3CAPRKDCTNNI3KGBA1
SCHEMBL8799311 0.78 EGFR (0.52) EGFRTNNI3KGBA1ITGB2ICAM1
SCHEMBL8319990 0.76 EGFR (0.54) EGFRCDK1PRKCAKHK
SCHEMBL8317533 0.75 EGFR (0.46) EGFRPIK3CAPRKDCTNNI3KHTT
SCHEMBL8315857 0.74 EGFR (0.49) EGFRPIK3CAPRKDCTNNI3KHTT
SCHEMBL8800521 0.74 EGFR (0.50) EGFRPIK3CAPRKDCTNNI3KHTT
SCHEMBL8799951 0.73 SCN9A (0.46) EGFRPIK3CAPRKDCSCN9A
SCHEMBL8314329 0.73 EGFR (0.49) EGFRPIK3CAPRKDCTNNI3KHTT
SCHEMBL8798398 0.72 SCN9A (0.48) EGFRTNNI3KSCN9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-1047778-C Pyrimido [5-4-d] pyrimidines, drugs containing these compounds, their use and process for preparing them THOMAE GMBH DR K (DE) 1999-12-29 — — CN disclosed
Send feedback